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Introduction
IL-10 is an anti-inflammatory cytokine spontaneously pro-
duced by monocytes/tissue macrophages in the rheuma-
toid joint [1], regulating IL-1 receptor antagonist
(IL-1Ra)/IL-1β and tumour necrosis factor (TNF)-α in
rheumatoid synovium [1,2]. Histological studies of syn-
ovium in rheumatoid arthritis (RA) have established that
macrophages are in close contact with T cells in the
inflamed interstitium [3], suggesting that contact signals
between macrophages and T cells may be of importance
in vivo in modulating cytokine production. Direct, contact-
mediated interaction between monocytes and activated
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lymphocytes in vitro induced synthesis of IL-1β, TNF-α,
IL-10 and metalloproteinases [4–8]. The mechanisms of
T-cell activation determine the monocyte cytokine profile.
T cells can be activated antigen-independently using a
combination of inflammatory cytokines (IL-2, IL-6 and TNF-
α) or IL-15 alone [9], suggesting a role for bystander acti-
vation of T cells in RA. These cytokine-stimulated cells
(Tck) did not induce monocyte production of IL-10 [6],
whereas T cells activated through the T cell receptor
(TCR)/CD3 system did.
Macrophages differentiated in vitro from monocytes mimic
tissue macrophages present in the synovial joint. Thus, dif-
ferentiation might influence the profile and amount of
cytokines. Macrophages primed with macrophage-colony-
stimulating factor (M-CSF) produce IL-10 in response to
CD40 ligation [10]. We therefore investigated whether dif-
ferentiation of monocytes to macrophages, cells more rep-
resentative of the rheumatoid synovium, would alter the
ability of T cells stimulated antigen-independently to
induce IL-10.
The signalling mechanisms by which T-cell interactions
induce macrophage IL-10 are unclear. We have shown
that the lipid kinase phosphatidylinositol 3-kinase (PI3K)
and its downstream substrate p70 S6-kinase (p70S6K)
mediate IL-10-induced responses [11]. However, little is
known about IL-10 production, although PI3K mediates
CD45-ligation-induced monocyte TNF-α production [12].
The aim of this study was to investigate signalling path-
ways downstream of cell-to-cell contact between T cells
and macrophages involved in IL-10 production in the
context of PI3K and p70S6K.
Materials and methods
Isolation of RA synovial-membrane mononuclear cells
and enrichment of CD3+ cells
Mononuclear cells from synovial membranes in rheumatoid
arthritis (RA-SMCs) were prepared by collagenase and
DNase digestion of membranes as described elsewhere
[1]. T cells were enriched using Dynabeads coated with
anti-CD3 antibodies in accordance with the manufactur-
er’s specifications (Dynal, Bromborough, Wirral, UK). The
resulting RA synovial-membrane T cells (RA-Ts) were fixed
in glutaraldehyde before co-culture (see below). Non-
adherent cells were depleted from RA-SMCs by adher-
ence (see Supplementary materials and methods).
Purification of T lymphocytes and monocytes
Human peripheral blood mononuclear cells (PBMCs) were
obtained from density centrifugation of buffy coats from
human venous blood through Ficoll/Hypaque density cen-
trifugation medium (Nycomed Pharma AS, Oslo, Norway).
PBMCs were centrifugally elutriated in a Beckman JE6
elutriator (Beckman RIIC Ltd, High Wycombe, Bucking-
hamshire, UK). Lymphocyte and monocyte purity was
assessed by flow cytometry: T cells were routinely >90%
pure and monocytes >85% pure.
Stimulation and fixation of T lymphocytes
T cells were stimulated for 8 days in 25 ng/ml TNF-α,
25 ng/ml IL-2 and 100 ng/ml IL-6, using an established
technique [9]. Lymphocytes were fixed in glutaraldehyde
in accordance with the method previously described [6].
Differentiation of monocytes to macrophages
Monocytes were differentiated with M-CSF for 7 days in
accordance with the protocol used previously [10]. Adher-
ent cells were washed and removed from the plastic with
cell-dissociation medium (Sigma, Poole, UK). The resulting
adherent cells were washed and resuspended in RPMI-
1640/10% FCS medium (BioWhittaker Europe Ltd,
Verviers, Belgium) ready for use.
Cognate co-culture assay
M-CSF-primed macrophages were plated at 1 × 105
cells/well and allowed to settle in 96-well flat-bottomed
plates for 1 hour before addition of autologous T cells.
Macrophages were pretreated for 1 hour with the PI3K
inhibitors wortmannin and LY294002 or the p70S6K
inhibitor rapamycin. Fixed Tck or RA-Ts were added to
achieve a predetermined T:macrophage ratio of 5:1 for
maximal cytokine production and incubated for 24 hours,
after which supernatants were harvested and stored at
–20°C until ELISA. Alternatively, co-cultures were set up
in 12-well plastic tissue-culture plates at a T:macrophage
ratio of 5:1 with the macrophage density set at 5 × 106
per well, for western blot analysis of phosphorylated
protein kinase B (phospho-PKB) and phosphorylated
p70S6K (phospho-p70S6K). The culture was stimulated
for 30 min, after which cells were lysed (see Supplemen-
tary materials and methods).
Cytokine determination by ELISA
IL-10 sandwich ELISAs were carried out in accordance
with the manufacturer’s specifications (PharMingen Inter-
national, Oxford, UK). Assay was performed with a stan-
dard curve of recombinant human (rhu)IL-10 from
13–10,000 pg/ml [13] and showed no cross-reactivity
with any cytokine tested.
Western blot analysis of phospho-PKB and phospho-
p70S6K
After co-culture, cells were lysed on ice for 15 min in lysis
buffer (see Supplementary materials and methods) and
separated by SDS–PAGE and were western blotted in
accordance with the method described elsewhere [12].
Phosphorylated proteins were detected using antibodies
raised against phospho-PKB (ser473) and phospho-
p70S6K (thr389) and were compared with total protein
kinase B (PKB) and p70S6K.Arthritis Research    Vol 4 No 1 Foey et al.
Results
Tck induce macrophage-derived IL-10
Tck did not induce monocyte IL-10 production. We
wished to find out whether macrophages primed with M-
CSF would produce IL-10 in response to Tck, and they
did (192 ± 13 pg/ml) (Fig. 1). Fixed Tck did not secrete
cytokines but induced cytokine production by physical
contact with the macrophages: separation of the cell
types by a semipermeable membrane insert abrogated
cytokine production.
Tck induction of macrophage IL-10 is PI3K- and
p70S6K-dependent
The role of PI3K in induction of macrophage IL-10 by Tck
was addressed using the PI3K inhibitors LY294002 and
wortmannin. LY294002 dose-dependently inhibited
macrophage IL-10 production (control cells produced
176 ± 7 pg/ml versus 39 ± 34 pg/ml for cells in 25 µM
LY294002) (Fig. 2a). These data were considered PI3K-spe-
cific, as these results were reproduced by wortmannin, which
(at 500 nM) suppressed IL-10 from 555 ± 125 pg/ml to
140 ± 22 pg/ml (Fig. 2b). PI3K activation was further shown
by phosphorylation of a downstream effector, PKB, which is
phosphorylated at ser473 upon interaction of macrophage
with Tck (Fig. 2c, lane 3). This PKB activation was abro-
gated by wortmannin (lane 4) and LY294002 (lane 5).
Because activation of p70S6K is both PI3K-dependent
[14,15] and PI3K-independent [16,17], we investigated
whether p70S6K is involved in Tck induction of IL-10,
using rapamycin, the inhibitor of mammalian target of
rapamycin (mTOR), an upstream activator of p70S6K.
Rapamycin dose-dependently suppressed macrophage IL-
10 (control cells produced 192 ± 13 pg/ml, versus
38 ± 7 pg/ml for cells in 1 nM rapamycin) (Fig. 2d).
Western blot analysis showed that p70S6K and its
nuclear isoform p85S6K are activated upon macrophage
interaction with Tck: p70S6K was phosphorylated at
Thr389 (Fig. 2e, lane 2). Activation of p70S6K was PI3K-
independent, however, as it was not suppressed by wort-
mannin (lane 3) or LY294002 (lane 4).
RA-Ts induce IL-10 production by peripheral blood
monocytes
We investigated whether RA-Ts were capable of inducing
IL-10. Neither fixed RA-Ts nor elutriated monocytes spon-
taneously produce IL-10. When the two cell types were
co-cultured, however, monocytes produced IL-10
(146 ± 26 pg/ml at a ratio of 7:1 T cells:macrophages
[T:M]; Fig. 3a). This IL-10 production was a consequence
of physical interaction between the cells, as it was abro-
gated by separating them with a semipermeable mem-
brane. In addition, RA-Ts induced IL-10 upon interaction
with M-CSF-primed macrophages, while these
macrophages produced similar or higher levels of IL-10 in
co-culture (243 ± 28 pg/ml at a T:M ratio of 7:1; Fig. 3b).
RA-T induction of macrophage IL-10 production is PI3K-
and p70S6K-dependent
This report establishes that RA-Ts induce IL-10 produc-
tion by monocytes and M-CSF-primed macrophages. To
compare signalling events between Tck and RA-Ts
leading to macrophage IL-10 production, we investigated
PI3K and p70S6K involvement. In co-cultures of RA-Ts
with M-CSF-primed macrophages at a T: macrophage
ratio of 5:1, IL-10 production was 178 ± 19 pg/ml; pro-
duction was suppressed to 68 ± 4 pg/ml and
39 ± 9 pg/ml by rapamycin and wortmannin, respectively
(Fig. 4).
Spontaneous IL-10 production by RA-SMCs is
suppressed by depletion of nonadherent cells
Macrophages and T cells from synovial tissue in RA
produce IL-10 [1]. To investigate cognate cell interactions
in regulating IL-10 production in this tissue, we cultured
RA-SMCs as a whole population or after depletion of the
nonadherent, T-cell-rich fraction. Depletion of nonadherent
cells suppressed spontaneous IL-10 production: upon in
vitro culture (Fig. 5), the whole population of RA-SMCs
produced 547 ± 16 pg/ml IL-10, adherent cells produced
82 ± 45 pg/ml and nonadherent cells produced
16 ± 5 pg/ml.
Figure 1
Cytokine-stimulated T cells induce IL-10 production by M-CSF-primed
macrophages in a contact-dependent manner. Cytokine-stimulated 
T cells were co-cultured with macrophages and monocytes that had
been primed with M-CSF. In some co-cultures, semipermeable
membranes were inserted to separate the two types of cell being
incubated (indicated on the chart by ‘insert’). Bars show mean
concentrations of IL-10 in triplicate culture supernatants ± SD, for a
representative of N = 5 replicate experiments. Macro = M-CSF-primed
macrophages; M-CSF = macrophage-colony-stimulating factor; 
Mono = monocytes.Wortmannin and LY294002 differentially regulate
spontaneous production of IL-10 by RA-SMCs
We have established that PI3K regulates Tck induction of
macrophage IL-10 and wished to investigate PI3K-depen-
dence of IL-10 production in the rheumatoid synovium.
Therefore, LY294002 and wortmannin were used on RA-
SMCs. LY294002 dose-dependently inhibited spontaneous
IL-10 production (control cells produced 208 ± 27 pg/ml
versus 112 ± 17 pg/ml for cells in 5 µM LY294002),
whereas wortmannin did not (control 208 ± 27 pg/ml com-
pared with 191 ± 25 pg/ml at 500 nM) (Fig. 6).
Discussion
M-CSF-primed macrophages, unlike monocytes, produce
IL-10 when stimulated by Tck. The ability of M-CSF-
primed macrophages to produce IL-10 in response to Tck
as well as other stimuli such as CD40 ligation [10] indi-
cates that M-CSF priming per se is essential for IL-10 pro-
duction, biasing membrane-receptor expression or
signalling networks. M-CSF is required to preprogramme
monocyte differentiation, as addition to monocyte co-
culture failed to induce IL-10. M-CSF is readily detected in
the RA joint (reviewed [18]), and this may explain why IL-
10 is found in RA-SMC cultures [1].
Tck may represent the T-cell phenotype in the rheumatoid
synovium [6,9], and interaction with M-CSF-primed
macrophages may mimic the mechanism of IL-10 produc-
tion in the rheumatoid joint. In support of this hypothesis,
spontaneous IL-10 production by RA-SMCs was reduced
Available online http://arthritis-research.com/content/4/1/064
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Figure 2
Induction of macrophage IL-10 by cytokine-stimulated T cells (Tck) is PI3K- and p70S6K-dependent. Tck were co-cultured with M-CSF-primed
macrophages at a T:macrophage ratio of 5:1. Before co-culture, macrophages were treated for 1 hour with PI3K inhibitor LY294002 (a) or
wortmannin (b) or with the p70S6K inhibitor rapamycin (d). Bars show mean IL-10 concentrations in triplicate culture supernatants ± SD, for a
representative of N = 5 replicate experiments. Western blot analysis of activated phospho-PKB (c) shows that the downstream effector PKB was
activated by Tck and that the effect was abrogated by wortmannin (500 nM) and LY294002 (5 µM). Lane 1, macrophage control; 2, Tck control; 3,
macrophage+Tck; 4, macrophage+Tck+wortmannin (500 nM); 5, macrophage+Tck+LY294002 (5 µM). In addition, Tck activate macrophage
p70S6K, which is PI3K-independent (e). Lane 1, macrophage control; 2, macrophage+Tck; 3, macrophage+Tck+wortmannin (500 nM); 4,
macrophage+Tck+LY294002 (5 µM). Data are representative of N = 3 replicate experiments. M-CSF = macrophage-colony-stimulating factor;
p70S6K = p70 S6-kinase; p85S6K = p85 S6-kinase (nuclear isoform of p70 S6-kinase); phospho-p70S6K = phosphorylated p70 S6-kinase;
(phospho-)PKB = (phosphorylated) protein kinase B; PI3K = phosphatidylinositol 3-kinase. *P < 0.05, **P < 0.01, ***P < 0.001.upon depletion of the nonadherent (T-cell enriched) frac-
tion of the cell population. In addition, RA-Ts and Tck both
induced macrophage IL-10. However, RA-Ts also induced
monocyte IL-10 whereas Tck did not, suggesting that
although these two types of T cell express similar pheno-
types, there maybe undefined membrane proteins present
on RA-Ts or that there may be higher expression of such
proteins in RA-Ts than in Tck.
PI3K positively regulates Tck-induced macrophage IL-10
production. Spontaneous IL-10 production by RA-SMCs
was also PI3K-dependent, as LY294002 inhibited
cytokine production. Wortmannin, however, did not affect
IL-10 production, in contrast with Tck, which induced
IL-10 in macrophages. This difference in sensitivity to
wortmannin between macrophages and RA-SMCs may
represent a potency effect or differential utilisation of PI3K
isoforms. The distal PI3K signalling molecules, PKB and
Arthritis Research    Vol 4 No 1 Foey et al.
Figure 3
T cells from synovial membranes in rheumatoid arthritis (RA-Ts) induce
production of IL-10 by monocytes and macrophages. RA-Ts were co-
cultured with resting monocytes (a) or M-CSF-primed macrophages
(b). Bars show mean IL-10 in triplicate culture supernatants ± SD, for
a representative of N = 3 replicate experiments. Macros = M-CSF-
primed macrophages; M-CSF = macrophage-colony-stimulating factor;
Monos = monocytes; T:M = ratio of RA-Ts to (panel a) monocytes or
to (panel b) M-CSF-primed macrophages. *P < 0.05, **P < 0.01, 
***P < 0.001.
Figure 4
Induction of macrophage IL-10 production by T cells from synovial
membranes in rheumatoid arthritis (RA-Ts) is PI3K- and p70S6K-
dependent. RA-Ts were co-cultured with M-CSF-primed macrophages
in the presence or absence of the PI3K inhibitor wortmannin (50 nM)
or the p70S6K inhibitor rapamycin (1 nM). Bars show mean IL-10 in
triplicate culture supernatants ± SD, for a representative of N = 3
replicate experiments. p70S6K = p70 S6-kinase; PI3K =
phosphatidylinositol 3-kinase; Rapa = rapamycin; T:M = ratio of 
RA-Ts:macrophages; Wort = wortmannin. *P < 0.05, **P < 0.01.
Figure 5
Spontaneous production of IL-10 by mononuclear cells from synovial
membrane in rheumatoid arthritis (RA-SMCs) is dependent on
interactions between adherent and nonadherent cells. RA-SMCs
(‘whole population’), SMC adherent cells (depleted of nonadherent
cells) and nonadherent cells (T-cell enriched) were cultured in 24-well
plastic tissue-culture plates (1 × 106 cells/ml per well) for 24 hours.
Bars show mean IL-10 in triplicate culture supernatants ± SD, for a
representative of N = 3 replicate experiments. **P < 0.01,
***P < 0.001.p70S6K [19–22] were also activated. The suppression of
macrophage IL-10 by rapamycin suggests that PI3K-
dependent IL-10 production is p70S6K-dependent.
Upstream regulators of p70S6K include mTOR [23], PI3K
[24], MAPK (mitogen-activated protein kinase) [25] and
PKB [26]. It is unclear whether p70S6K is downstream of
PI3K or represents an alternative, independent pathway.
Several studies have found p70S6K to be PI3K-depen-
dent [14,15] as well as PI3K-independent, downstream of
PKC and p42/44 MAPK [16,17]. We have found that
macrophage IL-10 requires PI3K and p70S6K activation;
however, p70S6K activation appears to be PI3K-indepen-
dent, as neither of the PI3K inhibitors suppressed
p70S6K phosphorylation.
These data show that the interaction between Tck and
macrophages induces the anti-inflammatory cytokine
IL-10. The production of this cytokine resulting from such
interactions is regulated by PI3K and p70S6K. Studies of
the signalling pathways involved in the regulation of proin-
flammatory and anti-inflammatory mediators may define
therapeutic targets for chronic inflammatory diseases
such as RA.
Conclusion
M-CSF-primed monocytes produce IL-10 upon interaction
with Tck. We observed that the signalling pathway
involved in macrophage IL-10 production and in RA syn-
ovial tissue cells is PI3K- and p70S6K-dependent.
(For more methodologies and results, see Supplementary
material)
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Supplementary material
Supplementary materials and methods
Reagents
IL-2, IL-6 and TNF-α were kind gifts from Dr U Gubler
(Hoffmann-La Roche, Nutley, NJ), Dr P Ramage (Sandoz,
Pharma Ltd, Basel, Switzerland) and Dr W Stec (Centre of
Macromolecular Studies, Lodz, Poland), respectively. IL-10
and TNF-α ELISA reagents were purchased from PharMin-
gen International (Oxford, UK). The inhibitors LY294002,
wortmannin and rapamycin were purchased from Sigma
(Poole, Dorset, UK) and antibodies against PKB, and
p70S6K from New England BioLabs (UK) Ltd (Hitchin,
Hertforshire, UK). All reagents were tested for the pres-
ence of lipopolysaccharide/endotoxin contamination and
were found to be below the lower level of detection of the
limulus amaebocyte assay (BioWhittaker, Berkshire, UK).
Isolation of RA synovial-membrane mononuclear cells
and enrichment of CD3+ cells
RA synovial-membrane mononuclear cells (RA-SMCs)
were obtained from samples of synovial-membrane tissue
provided by the Rheumatology Clinic, Charing Cross Hos-
pital, London, UK. All patients gave their signed consent,
and ethical approval was obtained from the Riverside
Research Ethics Committee (London). Patients met the
American College of Rheumatology (ACR) 1987 revised
criteria for RA.
In brief, tissue was cut into small pieces and digested in
medium containing 0.15 mg/ml DNAse type I (Sigma, UK)
and 5 mg/ml collagenase (Roche, UK) for 2 hours at
37°C. Cell debris was excluded by passing cells through a
nylon mesh. Cells were then washed and collected in
RPMI/10% FCS at a density of 1 × 106 cells/ml and used
immediately for spontaneous cytokine production by RA-
SMCs, or CD3+ T cells/nonadherent cells were depleted
from adherent cells. T cells were enriched using direct,
positive selection using Dynabeads (Dynal) coated with
anti-CD3 antibodies. Mononuclear cells (1 × 107) were
treated with 100 µl anti-CD3-coated Dynabeads for
20 min at 4°C under conditions of constant rotation. Cells
attached to beads were separated from unbound cells by
using a magnetic particle concentrator (Dynal) and cul-
tured for 6 hours at 37°C. Detached cells were removed
from the beads by washing them twice in medium, in the
presence of the magnet. CD3+ T cells obtained were of
high purity (>95%) and viability (>90%). RA CD3+ T cells
were predominantly CD4+ CD45RO+. In addition, the T-
cell activation markers human leukocyte antigen (HLA)-DR
and CD69 were also present, suggesting that RA CD3+ T
cells were of an activated, memory phenotype closely
resembling that of Tck [6]. The resulting RA-Ts were sus-
pended in RPMI 1640 medium ready for fixation before
co-culture assays (see below). Nonadherent cells were
depleted from RA-SMCs: briefly, RA-SMCs were adjusted
to a density of 2 × 106 cells/ml in RPMI 1640/5% FCS
and left to adhere to plastic 6-well plates for 2 hours at
37°C, after which nonadherent cells were removed and
adherent cells washed twice in RPMI 1640 medium.
Adherent cells were removed and cultured overnight, and
again nonadherent cells were washed off with RPMI 1640
medium. The resulting adherent RA-SMCs were harvested
and resuspended to a density of 2 × 106 cells/ml ready for
comparison of their IL-10 production with spontaneous
production by whole-population RA-SMCs.
RA-Ts isolated from synovial tissue by positive selection
using magnetic beads coated with anti-CD3 antibodies
may become activated by the beads. Therefore, we inves-
tigated the ability of such beads to further stimulate theseAvailable online http://arthritis-research.com/content/4/1/064
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cells. We found that CD3+ separated RA-Ts behaved like
nonadherent (T-cell enriched, >70% CD3+) RA-SMCs
with respect to the ability to induce monocyte or
macrophage production of IL-10 and TNF-α. Also, stimula-
tion of RA-Ts for 48 hours in culture by immobilised anti-
CD3 did not significantly alter upregulation of the
activation markers CD69 and HLA-DR or proliferation
when compared with RA-Ts alone. In addition, our group
has noted that with respect to macrophage cytokine pro-
duction and activation marker analysis, RA-T cells posi-
tively selected using beads coated with anti-CD2
antibodies behaved like nonadherent (T-cell-enriched) RA-
SMCs and RA-Ts separated using anti-CD3 antibodies.
RA-T cells are generally of an activated phenotype (pre-
dominantly CD45RO+ HLA-DR+ CD69+), and, unlike their
unstimulated peripheral blood counterparts, are not signifi-
cantly stimulated upon separation by anti-CD3 coated
magnetic beads.
Purification of T lymphocytes and monocytes
Human PBMCs were obtained from density centrifugation
of human venous blood buffy coats, purchased from the
North London Blood Transfusion Service (Colindale, UK)
through Ficoll/Hypaque (specific density 1.077 g/ml;
Nycomed Pharma). PBMCs were centrifugally elutriated in
a Beckman JE6 elutriator. Lymphocyte and monocyte
purity were assessed by flow cytometry of fluorochrome-
conjugated anti-CD3, anti-CD19, anti-CD14 and anti-
CD45 antibodies (Becton Dickinson, Oxford, UK). Both
types of cell were routinely >90% pure (T cells, >90%
CD3+, <4% CD19+, <3% CD14+; and monocytes,
>90% CD14+, <0.5% CD19+, <8% CD3+).
Stimulation and fixation of T lymphocytes
Purified T cells were routinely resuspended in RPMI
1640/10% human AB+ serum at a density of 1 × 106/ml
and stimulated for 8 days at 37°C/5%CO2, in a modified
version of the technique developed by Unutmaz and col-
leagues [9]. To generate Tck, we cultured the lymphocytes
for 8 days in the presence of saturating levels of the
cytokines TNF-α (25 ng/ml), IL-2 (25 ng/ml) and IL-6
(100 ng/ml). Lymphocytes were then harvested and
washed twice in PBS before fixation for 1 min on ice in
PBS/0.05% glutaraldehyde. This fixation solution was neu-
tralised to pH 7.0 by addition of an equal volume of 0.2 M
glycine/RPMI. Fixed cells were washed twice in RPMI
medium and finally resuspended in RPMI/5% FCS and
stored at 4°C until the experiment. Cells were routinely used
up to 3 days after fixation without any reduction in magni-
tude of the cytokine response induced in the cognate assay.
Cognate co-culture assay
M-CSF-primed macrophages were washed in serum-free
RPMI 1640 medium and plated at a density of 1 × 105
cells/well in RPMI 1640/10% FCS and were allowed to
settle in 96-well flat-bottomed plate wells for at least
1 hour before addition of autologous T cells (cytokine pro-
files/amplitudes were irrespective of whether T cells were
autologous or allogeneic MHC-mismatched, data not
shown). When necessary, macrophages were pretreated
for 1 hour with the PI3K inhibitors wortmannin or
LY294002, or with the p70S6K inhibitor rapamycin. For
maximal cytokine production, fixed allogeneic T cells or
CD3+ RA-T cells were added to achieve a predetermined
T-cell:macrophage ratio of 5:1. Each well was topped up
to 200 µl with RPMI 1640/10% FCS. Each test condition
was carried out in triplicate in each assay. The resulting
co-culture assay was incubated at 37°C/5%CO2 for
24 hours. All inhibitor concentrations used in this study
were noncytotoxic to macrophages or RA-SMCs as deter-
mined by trypan blue exclusion and MTT assays. Super-
natants were harvested and stored at –20°C until ELISA.
In the case of phospho-PKB and phospho-p70S6K, the
cognate co-culture was set up in 12-well plastic tissue-
culture plates at a T-cell:macrophage ratio of 5:1, with the
macrophage density set at 5 × 106 per well. Culture was
stimulated for 30 min at 37°C, and the cells were then
lysed (see western blot analysis).
Western blot analysis of phospho-PKB and p70S6K
T cells and macrophages were co-cultured at a ratio of
5:1, where macrophages were seeded at a density of
5×1 0 6 cells/ml in 24-well plates in RPMI 1640/10%
FCS. When inhibitors were used, the macrophages were
pretreated for 1 hour before stimulation by the addition of
fixed T cells and stimulated for 30 min before harvesting of
cell lysates. The stimulation time was previously defined as
optimal for activation of both PKB and p70S6K. After stim-
ulation, cells were lysed on ice for 15 min in lysis buffer
(1% NP-40, 200 mM NaCl, 0.1 mM EDTA, 1 mM dithio-
threitol, 1 mM Na3VO4, 1 mM NaF, 1 mM phenylmethylsul-
fonyl fluoride, 10 µg/ml leupeptin, 10 µg/ml pepstatin and
10 µg/ml aprotinin). Lysed samples were separated on
10% SDS–polyacrylamide gel and western blotted onto a
nitrocellulose membrane. Phosphorylated proteins were
detected using antibodies raised against phospho-PKB
and phospho-p70S6K, followed by anti-rabbit horseradish
peroxidase conjugate and detection by enhanced chemilu-
minescence (ECL; Amersham Pharmacia Biotech UK Ltd,
Little Chalfont, Buckinghamshire, UK). Protein bands were
visualised by autoradiography using Hyperfilm (Amersham
Pharmacia Biotech UK Ltd).
Statistical analysis
Data were compared using GraphPad Prism version 3.0
(GraphPad Software, Inc, San Diego, CA, USA). Statisti-
cal significances were determined by Student’s t-test.
Supplementary results
Tck induce macrophage-derived IL-10 and TNF-α α
Previously, we found that Tck induced the production of
TNF-α but not IL-10 in monocytes from peripheral blood,and we wished to find out whether M-CSF-differentiated
macrophages would produce IL-10 and the proinflamma-
tory cytokine TNF-α in response to the same stimulus. M-
CSF-primed macrophages produced 192 ± 13 pg/ml
IL-10 (see Fig. 1) upon interaction with Tck. In addition, M-
CSF-primed macrophages produced 158 ± 23 pg/ml
TNF-α. In this procedure, fixed Tck did not secrete any
cytokines but induced cytokine production by physical
contact with the macrophages, as separation of the two
cell types by a semipermeable membrane abrogated the
production both of IL-10 and of TNF-α. Figure 1 shows a
representative experiment of IL-10 production; other
experiments varied in the amount of cytokine produced
(176 ± 7 to 1567 ± 134) but resulted in similar cytokine
profiles. Differences in the amount of cytokine produced
are thought to be a consequence of donor variation
between blood packs.
The effects of Tck on cytokine production were specific to
interaction of Tck or RA-Ts with monocytes/macrophages,
as the addition of an exogenous cytokine cocktail (IL-2/
IL-6/TNF-α) did not induce macrophage IL-10 production
as did fixed, unstimulated T cells in the presence of these
cytokines (data not shown). In addition, membrane
turnover would make it unlikely that surface binding of IL-2/
IL-6/TNF-α would regulate IL-10 production; if it did,
monocytes would be likely to produce IL-10 in this co-
culture.
Arthritis Research    Vol 4 No 1 Foey et al.
Supplementary Figure 1
Induction of macrophage TNF-α by cytokine-stimulated T cells (Tck) is differentially regulated by PI3K and p70S6K. Tck were added in co-culture
with M-CSF-primed macrophages at a T : macrophage ratio of 5:1. Macrophages were pretreated for 1 hour with indicated concentration of PI3K
inhibitors LY294002 (a) or wortmannin (b) or with the p70S6K inhibitor rapamycin (c) before co-culture for 24 hours at 37°C/5% CO2, after which
supernatants were harvested and stored at –20°C until ELISA. Bars show mean TNF-α in triplicate culture supernatants ± SD, for a representative
of N = 3 replicate experiments. M-CSF = macrophage-colony-stimulating factor; p70S6K = p70 S6-kinase; PI3K = phosphatidylinositol 3-kinase;
T:M = ratio of Tck to M-CSF-primed macrophages; TNF = tumour necrosis factor. *P < 0.05, **P < 0.01, ***P < 0.001.Tck induction of macrophage IL-10 and TNF-α α is PI3K-
dependent
The role of PI3K activity in Tck induction of macrophage
IL-10 production was addressed using the specific PI3K
inhibitors LY294002 and wortmannin. LY294002 inhib-
ited IL-10 production by M-CSF-primed macrophages in a
dose-dependent manner, whereas in controls, IL-10 pro-
duction (176 ± 7 pg/ml) was suppressed to
39 ± 34 pg/ml in 25 µM inhibitor (P = 0.0288), with a
50% inhibitory concentration (IC50) value of 3.4 µM (see
Fig. 2a). These data were considered a PI3K-mediated
event, as these results were reproduced by wortmannin, a
commonly used PI3K inhibitor. Wortmannin (500 nM) sup-
pressed IL-10 to 140 ± 22 pg/ml (IC50 = 4 nM), versus
555 ± 125 pg/ml in controls (P = 0.032) (see Fig. 2b).
Regulation of TNF-α, on the other hand, was potentiated
when PI3K was inhibited by LY294002 or wortmannin.
LY294002 (25 µM) augmented TNF-α production from
control levels of 158 ± 23 pg/ml to 802 ± 107 pg/ml
(P = 0.0133) (50% effective dose [ED50]=  6µM) (Sup-
plementary Fig. 1a). Wortmannin (500 nM) augmented
Tck-induced macrophage TNF-α from a control concentra-
tion of 76 ± 5 pg/ml to 321 ± 7 pg/ml (P = 0.0001)
(ED50 = 35 nM) (Supplementary Fig. 1b). These data
suggest that PI3K differentially regulates proinflammatory
TNF-α and anti-inflammatory IL-10 — IL-10 positively and
TNF-α negatively. In addition, PI3K activation was further
shown by the phosphorylation of a downstream effector
molecule, PKB/Akt. PKB is phosphorylated at ser473
upon interaction of macrophages with Tck (see Fig. 2c,
lane 3). The control lanes containing the macrophage
control (lane 1) and the T-cell control (lane 2) did not
exhibit PKB phosphorylation. The T-cell control, however,
did not blot for total PKB either, probably as a conse-
quence of the fixation protocol, which is likely to have
encouraged release of intracellular cytoplasmic contents.
However, the T-cell control did positively stain for CD3 or
LAT, molecules that are associated with the T-cell mem-
brane. This activation of PKB by Tck was abrogated by the
PI3K inhibitors wortmannin (lane 4) and LY294002 (lane 5).
Tck induction of macrophage IL-10 and TNF-α α is
p70S6K-dependent
Tck induction of macrophage IL-10 and TNF-α is p70S6K-
dependent. Previously, it had been reported that the acti-
vation of p70S6K is both PI3K-dependent [14,15] and
PI3K-independent [16,17]. It was therefore of interest to
find out whether p70S6K activation was involved in Tck
induction of IL-10, using rapamycin, the inhibitor of mTOR,
an upstream activator of p70S6K. Rapamycin suppressed
IL-10 by M-CSF-primed macrophages in a dose-depen-
dent manner. In Fig. 2d, IL-10 production was inhibited
from control levels of 192 ± 13 pg/ml to 38 ± 7 pg/ml by
1 nM rapamycin with an IC50 value of 6 pM (P = 0.006). In
addition, TNF-α was also inhibited by rapamycin, from
control (510 ± 33 pg/ml) to 56 ± 6 pg/ml at 1 nM
(P = 0.0013) (IC50 = 16 pM) (Supplementary Fig. 1c).
Western blot analysis showed that p70S6K and its
nuclear isoform, p85S6K, are activated upon macrophage
interaction with fixed Tck. p70S6K was phosphorylated at
Thr389 upon this interaction (see Fig. 2c, lane 2). The
activation of p70S6K was not dependent on PI3K activity,
however, as it was not suppressed by the PI3K inhibitors
wortmannin (lane 3) or LY294002 (lane 4) but was inhib-
ited by rapamycin (data not shown).
RA-Ts induce macrophage IL-10 and TNF-α α production
After demonstrating that Tck could induce IL-10 produc-
tion in M-CSF-primed monocytes, we investigated
whether RA-Ts and without any further activation also
could induce IL-10. Neither fixed RA-Ts nor freshly elutri-
ated peripheral blood monocytes spontaneously produce
IL-10 secreted into tissue culture supernatant. When
these cell types were co-cultured together, however,
monocyte IL-10 was produced (126 ± 35 pg/ml at a
T:macrophage ratio of 5:1 [P = 0.0305] and
146 ± 26 pg/ml at a ratio of 7:1 [P = 0.0128]) (Fig. 3a).
This IL-10 production is a consequence of physical inter-
action between these cells, as separation by a semiperme-
able membrane insert abrogated this production. The
ability of monocytes to produce IL-10 was shown using
lipopolysaccharide at 1 ng/ml as a positive control; IL-10
was routinely produced at levels greater than 200 pg/ml.
In addition, RA-T cells also induced IL-10 production upon
physical interaction with M-CSF-primed macrophages,
which produced similar or slightly higher concentrations of
IL-10 in co-culture (189 ± 23 pg/ml at a T:macrophage
ratio of 3:1 [P = 0.0047] rising to 243 ± 28 pg/ml at a
T:macrophage ratio of 7:1 [P = 0.009]) (Fig. 3b). RA-Ts
also induced macrophage TNF-α production (81 ± 21 pg/ml
at 3:1 [P = 0.0293], rising to 150 ± 26 pg/ml at 7:1
[P = 0.0047]) (Supplementary Fig. 2). These CD3+ RA-T
cells were predominantly CD4+ CD45RO+. In addition,
the T-cell activation markers HLA-DR and CD69 were
expressed, suggesting that RA-Ts were of an activated,
memory phenotype closely resembling that of Tck [6].
Spontaneous IL-10 and TNF-α α production by RA-SMCs
is suppressed by removal of nonadherent cells
We have shown previously that IL-10 is produced by both
macrophages and T cells in RA synovial joint tissue,
although the macrophages apear to be the predominant
source of this cytokine [1]. To explain the dynamics of
cognate cell interactions in regulating IL-10 production in
this tissue, we cultured the RA synovial cells either as a
whole population or after T-cell-rich nonadherent cells
were depleted from the adherent RA-SMCs. Depletion of
nonadherent cells suppressed the spontaneous IL-10 pro-
duced in whole-population cultures of RA-SMCs. RA-
SMCs spontaneously produce IL-10 and TNF-α over an
incubation period of up to 4 days. The spontaneous pro-
duction of TNF-α occurred in 6/8 tissue samples tested,
Available online http://arthritis-research.com/content/4/1/064
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284 pg/ml). IL-10 was produced by 8/9 tissue samples,
with a range of 38 to 1064 pg/ml (mean production =
420 pg/ml). Thus, in the representative experiment, the
whole population of RA-SMCs produced 547 ± 16 pg/ml
IL-10 upon in vitro culture (see Fig. 5). In comparison,
adherent cells produced 82 ± 45 pg/ml (P = 0.0031) and
nonadherent cells produced 16 ± 5 pg/ml (P = 0.0004),
the lower limit of detection of the IL-10 ELISA being
13 pg/ml. Depletion of nonadherent (T-cell enriched) RA-
SMCs suppressed the spontaneous production of TNF-α,
while the whole population of RA-SMCs produced
441 ± 7 pg/ml, adherent cells produced 293 ± 30 pg/ml
(P = 0.0173) and nonadherent cells produced
74 ± 11 pg/ml (P = 0.0006) (Supplementary Fig. 3a). In
an attempt to compare Tck with RA-Ts (nonadherent
SMCs), we added Tck back to RA-SMCs depleted of non-
adherent cells (SMCs–T) (Supplementary Fig. 3b). Fixed
Tck rescued both IL-10 and TNF-α production, while addi-
tion of Tck to SMCs–T increased IL-10 production from
36 ± 1 pg/ml to 474 ± 43 pg/ml and TNF-α from
13 ± 1 pg/ml to 804 ± 87 pg/ml.
Wortmannin and LY294002 differentially regulate
spontaneous IL-10 and TNF-α α production by RA-SMCs
Having established that PI3K regulates macrophage IL-10
production upon interaction with fixed Tck, we needed to
address the same question as regards the rheumatoid
synovium. Therefore, the specific PI3K inhibitors
LY294002 and wortmannin were used in the spontaneous
production of IL-10 by RA-SMCs. LY294002 dose-depen-
dently inhibited spontaneous IL-10 production, whereas
wortmannin did not. LY294002 suppressed IL-10 produc-
tion of control cells (208 ± 27 pg/ml) to 112 ± 17 pg/ml
(P = 0.05) and 27 ± 2 pg/ml (P = 0.007) for 5 µM and
50 µM, respectively. Wortmannin had no significant effect
on spontaneous IL-10 production, while control levels
resulted in 208 ± 27 pg/ml compared with 191 ± 25 pg/ml
Arthritis Research    Vol 4 No 1 Foey et al.
Supplementary Figure 2
T cells from synovial membranes in rheumatoid arthritis (RA-Ts) induce
macrophage TNF-α production. RA-Ts were co-cultured with M-CSF-
primed macrophages and incubated for 24 hours at 37°C/5% CO2,
after which supernatants were harvested and stored at –20°C until
ELISA. Bars show mean TNF-α in triplicate culture supernatants ± SD,
for a representative of N = 3 replicate experiments. Macros =
macrophages; M-CSF = macrophage-colony-stimulating factor; T:M =
ratio of RA-T to M-CSF-primed macrophages; TNF = tumour necrosis
factor. *P < 0.05, **P < 0.01.
Supplementary Figure 3
Spontaneous production of TNF-α by mononuclear cells from synovial
membrane in rheumatoid arthritis (RA-SMCs) is dependent on
interactions between adherent cells and nonadherent cells and
reconstituted by addition of cytokine-stimulated T cells (Tck). RA-
SMCs, SMC-adherent cells (depleted of nonadherent cells) and
nonadherent cells (T-cell enriched) were cultured in 24-well plastic
tissue culture plates at a density of 1 × 106 cells/ml per well for
24 hours at 37°C/5% CO2, after which supernatants were harvested
and stored at –20°C until ELISA. Depletion of nonadherent cells
suppressed cytokine production by the adherent population (SMC-T)
(a). Bars show mean TNF-α in triplicate culture supernatants ± SD, for
a representative of N = 2 replicate experiments. In addition, TNF-α
production is reconstituted by Tck (b). Tck were added to
nonadherent-cell-depleted SMCs (SMCs–T) at a Tck:SMC ratio of
5:1 and incubated for 24 hours at 37°C/5% CO2, after which
supernatants were harvested and stored at –20°C until ELISA. Bars
show mean TNF-α and IL-10 in triplicate culture supernatants ± SD,
for a representative of N = 2 replicate experiments. TNF = tumour
necrosis factor. *P < 0.05, ***P < 0.001.in 500 nM wortmannin (P = 0.387, NS). This lack of effect
of wortmannin on IL-10 production was not a conse-
quence of loss of activity, as the same wortmannin aug-
mented TNF-α production by RA-SMCs in the same
experiment (control levels of 74 ± 10 pg/ml were potenti-
ated to 205 ± 27 pg/ml [P = 0.0062], 252 ± 14 pg/ml
[P = 0.0004] and 425 ± 37 pg/ml [P = 0.002] by 50, 100
and 500 nM wortmannin respectively) (Supplementary
Fig. 4b). Again, this trend was repeated with LY294002,
though it was not as pronounced as with the
Tck/macrophage co-culture system, with the higher con-
centrations showing slight augmentation to spontaneous
TNF-α production by RA-SMCs (Supplementary Fig. 4a).
These data, again, demonstrate differential regulation by
PI3K, as with the Tck/macrophage co-culture system.
RA-T cell induction of macrophage IL-10 and TNF-α α
production is PI3K-dependent
This report establishes that RA-T cells isolated from RA-
SMCs are capable of inducing IL-10 production by freshly
elutriated monocytes and M-CSF-primed macrophages. In
an attempt to compare the signalling events leading to
macrophage IL-10 production between Tck and T cells
derived from rheumatoid synovial biopsy tissue, PI3K and
p70S6K involvement was determined by the use of wort-
mannin and rapamycin. Co-culture of RA-T cells with M-
CSF-primed macrophages at a T:macrophage ratio of 5:1
resulted in 178 ± 19 pg/ml IL-10, which was suppressed to
68 ± 4 pg/ml (P = 0.0097) and 39 ± 9 pg/ml (P = 0.0125)
for rapamycin and wortmannin, respectively (Fig. 4).
Rapamycin had little effect on RA-T induction of macrophage
TNF-α production, while in controls (87 ± 32 pg/ml), it was
elevated to 133 ± 16 pg/ml (P = 0.133, NS). Wortmannin
inhibition of PI3K, however, augmented TNF-α production
to 509 ± 65 pg/ml (P = 0.0033) (Supplementary Fig. 5).
Discussion and conclusion
PI3K appears to play a role in Tck and RA-T induction of
macrophage cytokine production, but caution is needed
when interpreting data using specific inhibitors. It is well
established that LY294002 and wortmannin are PI3K
inhibitors, with LY294002 being the more specific.
However, at high concentrations, wortmannin can inhibit
several other enzymes, including phospholipase A2, phos-
phatidylinositol 4-kinase, phospholipase D and myosin
light-chain kinase. To ascribe PI3K specificity to the obser-
vations being described, these inhibitors were routinely
tested for the ability to inhibit PI3K by abrogation of PKB
phosphorylation. In addition, the specificity of PI3K was
validated by the TNF-α augmentation (see Supplementary
Figure 1) where both wortmannin and LY294002 resulted
in similar responses. Because wortmannin irreversibly
inhibits PI3K, its lack of effect on RA-SMC IL-10 produc-
tion over 24 hours may reflect the turnover rate for PI3K in
these cells, which probably differs from that observed with
M-CSF-primed macrophages.
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Supplementary Figure 4
Inhibition of phosphatidylinositol 3-kinase (PI3K) augments TNF-α production by mononuclear cells from synovial membrane in rheumatoid arthritis
(RA-SMCs). RA-SMCs were cultured in the absence (controls) or presence of the PI3K inhibitors LY294002 (a) and wortmannin (b) in 24-well
plastic tissue-culture plates at 1 × 106 cells/ml per well for 24 hours at 37°C/5% CO2, after which supernatants were harvested and stored at
–20°C until ELISA. Bars show mean TNF-α in triplicate culture supernatants ± SD, for a representative of N = 4 replicate experiments. TNF =
tumour necrosis factor. **P < 0.01, ***P < 0.001.The supplementary data presented here suggest that the
signalling pathways involved in Tck-induced macrophage
IL-10 and TNF-α share a common component, p70S6K.
PI3K however, differentially regulates IL-10 and TNF-α
production — IL-10 positively, and TNF-α negatively. Nega-
tive regulation of TNF-α would appear to be independent
of IL-10, as neutralisation of endogenous IL-10 does not
affect wortmannin’s augmentation of macrophage TNF-α
upon interaction with Tck (data not shown). These obser-
vations of PI3K involvement appear to be reproducible by
RA-SMCs and RA-T/macrophage co-culture, potentially
validating the Tck/macrophage model for the study of
cytokine production with respect to cellular interactions in
the rheumatoid joint. These data suggest that the PI3K
pathway is a potential therapeutic target, activation of
which may induce IL-10 while concomitantly suppressing
TNF-α production, redressing the balance between pro-
inflammatory and anti-inflammatory cytokines produced in
the rheumatoid joint.
Arthritis Research    Vol 4 No 1 Foey et al.
Supplementary Figure 5
Induction of macrophage TNF-α production by T cells from synovial
membranes in rheumatoid arthritis (RA-Ts) is dependent on
phosphatidylinositol 3-kinase (PI3K). RA-Ts were added in co-culture
with macrophages primed with macrophage-colony-stimulating factor
at a RA-T:macrophage (T:M) ratio of 5:1 in the presence or absence
of the PI3K inhibitor wortmannin (50 nM) or the p70S6K inhibitor
rapamycin (1 nM) for 24 hours at 37°C/5% CO2, after which
supernatants were harvested and stored at –20°C until ELISA. Bars
represent mean TNF-α of triplicate culture supernatants ± SD, for a
representative of N = 2 replicate experiments. Macros =
macrophages; Rapa. = rapamycin; T:M = ratio of RA-Ts to M-CSF-
primed macrophages; TNF = tumour necrosis factor; Wort. =
wortmannin. **P < 0.01.